These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
289 related items for PubMed ID: 36348095
21. In vivo imaging and characterization of [(18)F]DPA-714, a potential new TSPO ligand, in mouse brain and peripheral tissues using small-animal PET. Vicidomini C, Panico M, Greco A, Gargiulo S, Coda AR, Zannetti A, Gramanzini M, Roviello GN, Quarantelli M, Alfano B, Tavitian B, Dollé F, Salvatore M, Brunetti A, Pappatà S. Nucl Med Biol; 2015 Mar; 42(3):309-16. PubMed ID: 25537727 [Abstract] [Full Text] [Related]
22. Quantitative assessment of translocator protein (TSPO) in the non-human primate brain and clinical translation of [18F]LW223 as a TSPO-targeted PET radioligand. Tan Z, Haider A, Zhang S, Chen J, Wei J, Liao K, Li G, Wei H, Dong C, Ran W, Li Y, Li Y, Rong J, Li Y, Liang SH, Xu H, Wang L. Pharmacol Res; 2023 Mar; 189():106681. PubMed ID: 36746361 [Abstract] [Full Text] [Related]
23. [18F]DPA-714 PET imaging for the quantitative evaluation of early spatiotemporal changes of neuroinflammation in rat brain following status epilepticus. Kaneko KI, Irie S, Mawatari A, Igesaka A, Hu D, Nakaoka T, Hayashinaka E, Wada Y, Doi H, Watanabe Y, Cui Y. Eur J Nucl Med Mol Imaging; 2022 Jun; 49(7):2265-2275. PubMed ID: 35157105 [Abstract] [Full Text] [Related]
24. Microglial Positron Emission Tomography Imaging In Vivo : Positron Emission Tomography Radioligands: Utility in Research and Clinical Practice. Ottoy J, De Picker L, Kang MS. Adv Neurobiol; 2024 Jun; 37():579-589. PubMed ID: 39207714 [Abstract] [Full Text] [Related]
25. Tracking Innate Immune Activation in a Mouse Model of Parkinson's Disease Using TREM1 and TSPO PET Tracers. Lucot KL, Stevens MY, Bonham TA, Azevedo EC, Chaney AM, Webber ED, Jain P, Klockow JL, Jackson IM, Carlson ML, Graves EE, Montine TJ, James ML. J Nucl Med; 2022 Oct; 63(10):1570-1578. PubMed ID: 35177426 [Abstract] [Full Text] [Related]
26. Microglial activation in Parkinson's disease using [18F]-FEPPA. Ghadery C, Koshimori Y, Coakeley S, Harris M, Rusjan P, Kim J, Houle S, Strafella AP. J Neuroinflammation; 2017 Jan 11; 14(1):8. PubMed ID: 28086916 [Abstract] [Full Text] [Related]
27. Resolving the cellular specificity of TSPO imaging in a rat model of peripherally-induced neuroinflammation. Vicente-Rodríguez M, Singh N, Turkheimer F, Peris-Yague A, Randall K, Veronese M, Simmons C, Karim Haji-Dheere A, Bordoloi J, Sander K, Awais RO, Årstad E, Nima Consortium, Cash D, Parker CA. Brain Behav Immun; 2021 Aug 11; 96():154-167. PubMed ID: 34052363 [Abstract] [Full Text] [Related]
28. TSPO imaging in animal models of brain diseases. Van Camp N, Lavisse S, Roost P, Gubinelli F, Hillmer A, Boutin H. Eur J Nucl Med Mol Imaging; 2021 Dec 11; 49(1):77-109. PubMed ID: 34245328 [Abstract] [Full Text] [Related]
29. In-vivo imaging of grey and white matter neuroinflammation in Alzheimer's disease: a positron emission tomography study with a novel radioligand, [18F]-FEPPA. Suridjan I, Pollock BG, Verhoeff NP, Voineskos AN, Chow T, Rusjan PM, Lobaugh NJ, Houle S, Mulsant BH, Mizrahi R. Mol Psychiatry; 2015 Dec 11; 20(12):1579-87. PubMed ID: 25707397 [Abstract] [Full Text] [Related]
30. TSPO Radioligands for Neuroinflammation: An Overview. Salerno S, Viviano M, Baglini E, Poggetti V, Giorgini D, Castagnoli J, Barresi E, Castellano S, Da Settimo F, Taliani S. Molecules; 2024 Sep 05; 29(17):. PubMed ID: 39275061 [Abstract] [Full Text] [Related]
31. Longitudinal positron emission tomography and postmortem analysis reveals widespread neuroinflammation in SARS-CoV-2 infected rhesus macaques. Nieuwland JM, Nutma E, Philippens IHCHM, Böszörményi KP, Remarque EJ, Bakker J, Meijer L, Woerdman N, Fagrouch ZC, Verstrepen BE, Langermans JAM, Verschoor EJ, Windhorst AD, Bontrop RE, de Vries HE, Stammes MA, Middeldorp J. J Neuroinflammation; 2023 Jul 29; 20(1):179. PubMed ID: 37516868 [Abstract] [Full Text] [Related]
32. Peripheral benzodiazepine receptor/18 kDa translocator protein positron emission tomography imaging in a rat model of acute brain injury. Nomura M, Toyama H, Suzuki H, Yamada T, Hatano K, Wilson AA, Ito K, Sawada M. Ann Nucl Med; 2021 Jan 29; 35(1):8-16. PubMed ID: 32989663 [Abstract] [Full Text] [Related]
33. Translocator protein (18 kDa) polymorphism (rs6971) explains in-vivo brain binding affinity of the PET radioligand [(18)F]-FEPPA. Mizrahi R, Rusjan PM, Kennedy J, Pollock B, Mulsant B, Suridjan I, De Luca V, Wilson AA, Houle S. J Cereb Blood Flow Metab; 2012 Jun 29; 32(6):968-72. PubMed ID: 22472607 [Abstract] [Full Text] [Related]
34. Kinetic analysis of the translocator protein positron emission tomography ligand [18F]GE-180 in the human brain. Feeney C, Scott G, Raffel J, Roberts S, Coello C, Jolly A, Searle G, Goldstone AP, Brooks DJ, Nicholas RS, Trigg W, Gunn RN, Sharp DJ. Eur J Nucl Med Mol Imaging; 2016 Nov 29; 43(12):2201-2210. PubMed ID: 27349244 [Abstract] [Full Text] [Related]
39. Central nervous system expression and PET imaging of the translocator protein in relapsing-remitting experimental autoimmune encephalomyelitis. Mattner F, Staykova M, Berghofer P, Wong HJ, Fordham S, Callaghan P, Jackson T, Pham T, Gregoire MC, Zahra D, Rahardjo G, Linares D, Katsifis A. J Nucl Med; 2013 Feb 29; 54(2):291-8. PubMed ID: 23321458 [Abstract] [Full Text] [Related]